Aspergillus fumigatus: Potential Threat for Asthma patients
Abstract
Asthma is a chronic inflammatory disease of the airways. In susceptible individuals it causes recurrent episodes of wheezing, breathlessness, chest tightness and cough. Inflammation can increase airway hyper responsiveness which can lead to infections by bacteria including atypical bacteria, fungi and viruses. Allergic Bronchopulmonary Aspergillosis (ABPA) is a disease of asthmatic subjects, is caused by hypersensitivity to Aspergillus antigens. It is life threatening disease associated with Aspergillus fumigatus colonization of the bronchial airway. A person with asthma who develops ABPA has difficulty in controlling their asthma despite using many medications. In the present study 140 patients with Asthma were analysed for presence of Aspergillus species in their sputum sample. To confirm their atopy total serum IgE was estimated. In order to determine their sensitisation for A. fumigatus, serum IgM for A. fumigatus was also tested. 4 patients (2.85%) showed presence of A. fumigatus in their sputum samples. All of them showed elevated levels of IgE which confirmed their allergic status. 17% patients showed elevated levels of A. fumigatus IgM antibodies which indicates sensitization of asthmatic subjects to A. fumigatus. Therefore it is recommended that while treating allergic patients presence of A. fumigatus in respiratory tract as well as presence of significant titres of antibodies against A. fumigatus should be considered. Focused treatment to irradicate A. fumigatus should be given so that A. fumigatus is cleared from respiratory tract.
Key words: Asthma, ABPA, A. fumigatus.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Tarfe Kishori S, Deshpande Sunita D
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/